Atlas Trials

A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

Clinical trial NCT07632573 · RECRUITING

Trial details

NCT number
NCT07632573
Sponsor
Benethera (Shaoxing) Biotechnology Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis AcuteIBD (Inflammatory Bowel Disease)CD - Crohn's Disease
Start date
2026-05-18
Primary completion
2026-12-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.